U.S. Markets open in 7 hrs 36 mins

Catalyst Pharmaceuticals, Inc. (CPRX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.40-0.04 (-1.64%)
At close: 3:59PM EDT
People also watch
IDRACYCCCLSNTHLDATHX
  • B
    Biscuitine Triscuit
    Biscuitine Triscuit
    My guess is we'll see a pull back close to 2.10 and then depending on news, maybe 3-5 by March.
  • a
    ahmetb
    ahmetb
    Any hope for this stock??
  • B
    Beeman
    Beeman
    Seems like there is a concerted exit occurring in CPRX...trends down, pops up, trends down, pops up, trends down...overall down but pops for the good ol' boys to exit nice and smooth...please confirm or disconfirm this observation...
  • B
    BillT
    BillT
    I survived.Just got the power and water back but I feel pretty lucky.I have friends that lost everything.I have a feeling it's going to be a while before we hear from Mike.Anyway I just wanted to check in.
  • L
    Laura
    Laura

    MEGA OPP on this one ..
    SLNO (MC $25 M) BLOCKBUSTER in Phase 3 /Rare Disease +Orphan Status /$2+ BILLION Market /NO Debt = REAL Unknown low float stock with 1000% upside Potential and more .Next billion dollar rare disease company like SRPT here .GLTA

    Soleno therapeutics (SLNO)

    Market Cap $25 Million
    Cash: $8 Million
    Price $0.51

    Shares Out: 47.6 Million ( 36 Million shares held by Insiders & Institutions)

    Initiating Coverage June 26, 2017
    http://www.lifescicapital.com/wp-content/uploads/Soleno.pdf

    •Company expects to initiate pivotal Phase III clinical trial by year-end 2017; will take approximately 9-12 months to complete

    Soleno Therapeutics, Inc. (Soleno) is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company is currently advancing its lead candidate, DCCR, a once-daily oral tablet for the treatment of PWS, into a Phase III clinical development program at the end of 2017.

    Market Opportunity for PWS is Substantial.

    While the lack of approved treatments for PWS alone make it difficult to assess the market, sales of Pfizer’s (NYSE: PFE)
    Genotrop in (somatropin) can provide some insight despite being indicate for PWS, in addition to, growth failure due to growth hormone deficiency(GHD),Turner syndrome,idiopathic short stature,and small for gestational age.This product achieved its highest revenue in 2008,with worldwide sales of approximately $900 million.While somatropin has been proven to improve growth and body composition, it does not affect the key disease component of hyperphagia and use is associated with substantial risk. Soleno is developing DCCR for the treatment of PWS,to help address the unmet need of this patient population. To assess the potential of DCCR for PWS, we performed a scenario analysis, which indicates that annual sales could be in the range of $1.1 billion given a moderate price point and 50% market penetrance.

  • C
    Charlie
    Charlie
    Good volume today!
  • S
    Sheena
    Sheena
    Just to ease everyone's mind, I called Catalyst Pharma a few minutes ago to see how they fared with the Irma (hurricane). The person I spoke to advised me that they made out just fine and are up and working. I was so relieve since I am a large share holder of Catalyst.
  • B
    BillT
    BillT
    I'm on the Space Coast of Florida so depending on what this storm does I may not be on for a while.It took almost 2 weeks to get power after Matthew last year so this could get ugly.For anyone in the path of this monster I wish you luck.Stay safe.
  • j
    joe
    joe
    Did the company ever provide an explanation for the recent delay? If so, what was it?
  • B
    Beeman
    Beeman
    irma coming, i hope the cprx data is stored in another state not in dade county...
  • J
    JohnnieS
    JohnnieS
    Mcenany just bought 20000 shares at $2.50+. Reported on InsiderMonkey today
  • B
    Beeman
    Beeman
    the pop in price yesterday near noon tells me someone found out something during their lunch hour...maybe a deal is being done!
  • B
    BillT
    BillT
    This may be the last time we see this kind of drop before we go up.I've been waiting for it.
  • J
    JohnnieS
    JohnnieS
    Ideas anyone? What's going on?
  • S
    Sevy
    Sevy
    In one year : Firedapse NDA approved, What will stock price be?

    Between 6 and 8?
  • S
    Steven
    Steven
    Is today's drop because of CPRX is located in Coral Gables, or is something else going on?
  • S
    Sheena
    Sheena
    CPRX is at a very low price today and it's a great time to buy more, if you can afford to. Remember, buy LOW and sell HIGH! SHEENA
  • B
    Beeman
    Beeman

    it was nice of the CEO to pick up 20,000 shares today...at $2.578 each...

    http://archive.fast-edgar.com//20170905/A322822CZ222H2Z2222E2WDZNQKVLZF23292/

  • S
    Sheena
    Sheena
    It amazes me that someone is willing to sell their shares at $2.40 today. They probably have to sell those shares because of a margin call - that happened to me before. I never buy a stock on margin anymore.
  • S
    Sheena
    Sheena
    Folks, I am new to this message board for CPRX and my advice to all is DON'T PANIC SELL! I am an investor and I never panic sell. Stand firm and CPRX will go back up, believe me. SHEENA